SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)

Form 483FOIA Uncovered

Dresden, -, GermanyFEI 3004835618Issued March 15, 2024

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3004835618.

Observations1

Issue DateMarch 15, 2024

StatusNo Warning Letter

Related Inspections7

Establishment Details

Firm: SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)
Location: Dresden, -, Germany
FEI Number: 3004835618
Product Type: Biologics
Issue Date: March 15, 2024
Country: Germany

Inspection History, 2009 to 2024

NAI1

VAI6

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) FDA Form 483, Dresden, March 15, 2024